期刊名称：EXPERIMENTAL AND MOLECULAR MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Welcome to Experimental & Molecular Medicine
Experimental & Molecular Medicine (EMM) is Korea’s first biochemistry journal and is relaunched as an Open Access, fully peer-reviewed international journal devoted to publishing the latest and most important advances in genetic, molecular and cellular studies of human physiology and diseases. The journal aims to communicate the improved clinical benefits for human health from the experimental and translational research performed using molecular tools. Areas that are covered include, but are not limited to, cancer biology, immunology, neuroscience, cardiovascular diseases, genetics and genomics, gene therapy and stem cells and regenerative medicine.
In March 2014, EMM published a special feature on Mucosal Immunity and Vaccines with a series of reviews providing an overview of current understanding in this area and covering a range of key topics including regulatory T cell vaccination, antigen targeting to M cells, mucosal mast cells and the role mucosal dendritic cells play in shaping mucosal immunity.
Aims and scope of journal
Experimental & Molecular Medicine is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.
Topics of particular interest within the journal's scope include, but are not limited to, those listed below:
- Cancer biology
- Immunology
- Neuroscience
- Cardiovascular biology
- Genetics and genomics
- Gene therapy
- Metabolic diseases
- Stem cells and regenerative medicine
- Physiology and diseases
- Molecular Medicine
The journal publishes peer-reviewed Original Articles and Reviews. In addition, Research Summaries are provided for selected articles. Editorial articles are brief comments written by the editor(s) of the journal or by guest editor(s) of Special Features based on the contents of the current issue or topical subjects that fall within the scope of the journal.
Reviews can be submitted by authors without invitation but authors are encouraged to submit an abstract of the review to the Editor-in-Chief (dmjue@catholic.ac.kr) to consider for suitability prior to submission of a full article. Submissions of Review articles from outstanding graduate students are also encouraged under the following conditions:
- An abstract of the review should be submitted to the Editor-in-Chief (dmjue@catholic.ac.kr) to consider for suitability prior to the submission of a full article
- The student's supervisor who has the most expertise in the area being reviewed must be a participatory co-author on the paper
- The article should encompass a critical assessment of an area: the timeliness of this assessment should be explicitly justified
Top of page
Citing articles in Experimental & Molecular Medicine
EMM uses the digital object identifier (DOI) as the primary means to identify papers, instead of the more traditional Volume / Issue / Consecutive page numbers. The DOI is an international, public, “persistent identifier of intellectual property entities” in the form of a combination of numbers and letters. For NPG content the DOI is assigned to an item of editorial content, providing a unique and persistent identifier for that item. The DOI system is administered by the International DOI Foundation, a not-for-profit organization. CrossRef, a not-for-profit organization, makes the DOI a reference linking standard and enables cross-publisher linking. It also maintains the lookup system for DOIs. NPG is a founding, and board, member of CrossRef.
To cite articles in EMM, you can give the paper's DOI at the end of the citation. For example, Experimental & Molecular Medicine papers should be cited in the form as specified by a journal or for example: Author(s) (Year) Article Title Exp Mol Med, page(s); (DOI 10.1038/emm.YEAR.XXX).
For your background information, the DOI has two components, a prefix (before the slash) and a suffix (after the slash). The prefix is a DOI resolver server identifier (10) and a unique identifier assigned to the publisher; for example, the identifier for NPG is 1038 and the entire DOI prefix for an article published by NPG is 10.1038. The suffix is an arbitrary number provided by the publisher; it can be composed of numbers and/or letters and does not necessarily have any systematic significance. Each DOI is registered in a central resolution database that associates it with one or more corresponding web locations (URLs).
Top of page
Impact Factor
2011 Impact Factor: 2.481*
Rank:
174/289 in the Biochemistry & Molecular Biology category
50/111 in the Medicine, Research & Experimental category
*2011 Journal Citation Reports® Science Edition (Thomson Reuters, 2012)
Top of page
Abstracted/indexed in
Google Scholar
Science Citation Index & Biological Abstracts (ISI - Thomson Reuters)
MedLine (Pubmed)
Chemical Abstracts (CAS)
EM Base (Elsevier Scopus)
Top of page
ISSN and eISSN
The international standard serial number (ISSN) for Experimental & Molecular Medicine is 1226-3613 and the electronic international standard serial number (eISSN) is 2092-6413.
Top of page
Funding
The journal is supported by a Korean Federation of Science and Technology Societies Grant funded by the Korean Government (MEST).
Instructions to Authors
Top of page
Did you know?
- That Experimental & Molecular Medicine is an online, open access journal.
- That Experimental & Molecular Medicine offers professionally written Research Summaries that provide an easily understood synopsis of the work and will accompany many of the articles published in the Journal.
- That the millions of users of nature.com can now sign up for an e-mail copy of the table of contents for the Experimental & Molecular Medicine issue in which your article is published.
- That Experimental & Molecular Medicine has an impact factor of 2.573.
Top of page
Benefits of publishing with EMM
Experimental & Molecular Medicine (EMM) is committed to publishing high quality, independently peer-reviewed research and review material.
The journal is published in partnership with Nature Publishing Group (NPG), which uses pioneering technologies, innovative formats and world class production to provide premium information for scientific researchers in the public and private sectors, government agencies and educators.
A key strength of NPG is its close relationship with the scientific community. Working closely with scientists, listening to what they say, and always placing emphasis on quality rather than quantity, has made NPG the leading scientific publisher at finding innovative solutions to scientists' information needs, both for the Nature-branded publications and those published on behalf of society partners, including KSBMB.
Publishing with Experimental & Molecular Medicine and NPG provides an author with a wide range of benefits:
Open access
As an open access journal, Experimental & Molecular Medicine content is freely available to all researchers worldwide ensuring maximum dissemination. Content is published online on a weekly basis to provide timely communication to the community and keep publication times to a minimum.
Authors of accepted manuscripts are charged an article-processing fee dependent upon article type and licence chosen. Please see the journal's Instructions to Authors for full price listing.
Research Summaries
NPG is committed to broadening the accessibility of research papers and reviews to as many readers as possible, thereby facilitating the widest dissemination of knowledge. To this end, NPG is introducing Research Summaries to EMM. A Research Summary is a professionally written, 100-150 word synopsis of a selected article that succinctly provides information to the reader about the aims, main outcomes and significant conclusions of the article. Published under a Creative Commons license, authors and others will be able to re-use, re-post, host and email Research Summaries to highlight the value of their work.
Creative Commons License
Experimental & Molecular Medicine articles are published either under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, a Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License, or a Creative Commons Attribution 3.0 Unported Licence at the free choice of the authors. The latter license permits derivative works, even commercially. More information about license choice can be found on the Open Access page.
Online submission - reducing publication times
Experimental & Molecular Medicine has adopted NPG's online submission system, which allows authors to submit papers via the Web. This system speeds up the submission and refereeing process, and allows you to view the status of your paper online.
Quality
Authors who choose to publish in any NPG journal can be assured that its staff's publishing, editorial and production skills are committed to maintaining the highest possible quality and standards.
Regular free e-mail alerts
Content published in Experimental & Molecular Medicine has the potential to reach scientists around the world who have signed up for NPG's free table of contents e-alerts, ensuring additional exposure for authors. These e-alerts will inform recipients of the articles published in the journal on a monthly basis and allow them to click through and read the full text. To sign up click here.
Focused subject areas on nature.com
From immunology to physics, genetics to materials, subject-specific areas provide a focused environment for readers, providing a monthly updated focus for a particular field.
Abstracting and indexing
Extensive reference linking to MEDLINE, ISI, Chemport and others via services such as Crossref and DOI numbers provide seamless online linking between articles and databases.
Media coverage
The Nature press office provides information about exceptionally interesting papers published throughout NPG. More than 2,000 journalists and media organizations worldwide subscribe to the press service, ensuring that papers receive maximum exposure in the world's most important media channels including newspapers, magazines, radio and television.
Editorial Board
Editors
Editor-in-Chief
Dae-Myung Jue 
Dae-Myung Jue PhD is a Professor in the Department of Biochemistry, Catholic University of Korea, Seoul. His research interests are proteins and enzymes involved in inflammatory diseases, and the development of strategies to control their expression. Dr. Jue graduated from Seoul National University and KAIST and received his PhD degree from the Catholic University of Korea in 1981. From 1987 to 1989, he was a postdoctoral Fogarty Fellow with Dr. A. Cerami at the Rockefeller University in New York. Since 1981, he has been working in the Department of Biochemistry, Catholic University of Korea. Dr. Jue was an Associate Editor of Korean Journal of Biochemistry from 1991 to 1995, and since then has continued his editorial work with Experimental & Molecular Medicine. He was the President of the Korean Society of Medical Biochemistry and Molecular Biology in 2008 and is a member of the National Academy of Medicine of Korea.
Associate Editors
Kyungho Choi 
Kyungho Choi MD, PhD is a molecular immunologist and an Associate Professor at the Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Korea. He received his MD from Seoul National University College of Medicine in 1994 and his PhD from the Department of Biochemistry and Molecular Biology of the same college in 1998. He developed his career as an immunologist when he worked as a postdoctoral fellow in Dr. Ron Schwartz's laboratory (Laboratory of Cellular and Molecular Immunology) at NIH, USA from 2001 to 2005. After moving back to Korea in 2005, he joined the Research Institute National Cancer Center as a Senior Scientist. In 2012, he moved to his current position at the Seoul National University. His current research focuses on molecular mechanism of T cell tolerance and its application to cancer immunotherapy and treatment of autoimmune diseases.
Sangdun Choi 
Sangdun Choi is currently the Chair of the Department of Biological Sciences and a Professor at the Department of Molecular Science and Technology in Ajou University, Korea. He joined the faculty of the Department of Molecular Science and Technology, Ajou University, as an Associate Professor in 2006. His research interests include Toll-like receptor signaling, innate immunity, cellular signaling and systems biology. He earned his PhD at the Texas A&M University, USA. He was one of the pioneers in the development of Bacterial Artificial Chromosomes (BACs). He was instrumental in the construction of a complete human BAC library for the Human Genome Project (HGP). He was also involved in the second consortium, Alliance for Cellular Signaling (AfCS). Furthermore, he served as the Director of the Transcription Analysis Laboratory at the California Institute of Technology (Caltech), USA. He has published more than 200 scientific articles in international journals including Nature, Science, Nature Biotechnology, Blood and Proceedings of the National Academy of Sciences. He has edited seven books including Encyclopedia of Signaling Molecules, Systems Biology for Signaling Networks and Introduction to Systems Biology. He is an academic editor of PLoS ONE and an active editor for several other international journals. He has also served as a reviewer for several international journals.
Yoon-Keun Kim 
Yoon-Keun Kim, MD, PhD is a physician scientist. He received his MD from Seoul National University in 1987 and received his PhD in 1997. From 2002 to 2003, he was a Visiting Assistant Professor at Yale University, USA. Currently, he is a Professor in the Department of Life Science at the Pohang University of Science and Technology (POSTECH), Korea. His research interest was the pathogenesis of allergic diseases and chronic inflammatory diseases such as asthma, atopic dermatitis, diabetes, obesity, gastritis and inflammatory bowel diseases. His research focused on the physiological relevance of the pathogenesis of allergic diseases, and he published a paper about the endotoxin contaminated allergen induced asthma model. More recently, his research interest has been the relationship between extracellular vesicles (EV) from bacteria and inflammatory diseases. He reported that EV from S. aureus can induce atopic dermatitis-like inflammation and that EV from E.coli can cause sepsis-like systemic inflammation. He has tried to link basic science to clinical research, and has therefore formed collaborations with many physicians.
Young-Han Lee
Young-Han Lee received his DVM from the Seoul National University in 1982 and a PhD degree in biochemistry from the Pohang University of Science and Technology (POSTECH) in 1995. From 1996 to 1997, he was a postdoctoral fellow with Dr. Jaekyoon Shin at the DanaFarber Cancer Institute, Harvard Medical School in Boston. He is now a Professor in the Department of Biomedical Science and Technology, Konkuk University, Seoul, Korea. His research has focused on the regulatory mechanism of gene expression, control of tumor microenvironment, cell cycle, apoptosis, and autophagy in tumor cells.
Editorial Board
Xuetao Cao, Chinese Academy of Medical Sciences, Beijing, China
Arnold I. Caplan, Case Western Reserve University, Cleveland, U.S.A.
Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, U.S.A.
Kang-Yell Choi, Yonsei University, Seoul, Korea
Jang-Su Chun, Gwangju Institute of Science and Technology, Gwangju, Korea
Yeun-Jun Chung, The Catholic University of Korea, Seoul, Korea
Henricus J. Duckers, Erasmus University, Rotterdam, Netherlands
Weiping Han, Singapore Bioimaging Consortium, Singapore, Singapore
Bong-Kiun Kaang, Seoul National University, Seoul, Korea
Hyo-Soo Kim, Seoul National University, Seoul, Korea
Jae Bum Kim, Seoul National University, Seoul, Korea
Sung Soo Kim, Kyung Hee University, Seoul, Korea
Gou Young Koh, Korea Advanced Institute of Science and Technology, Daejeon, Korea
Issei Komuro, Osaka University Graduate School of Medicine, Suita, Japan
Charles Lee, Brigham and Women's Hospital, Boston, U.S.A.
Inkyu Lee, Kyungpook National University, Daegu, Korea
Jae-Ho Lee, Ajou University, Suwon, Korea
Sang-Hun Lee, Hanyang University, Seoul, Korea
Sanghyuk Lee, Ewha Womans University, Seoul, Korea
Seung Hoon Lee, National Cancer Center, Goyang, Korea
Dae-Sik Lim, KAIST, Daejeon, Korea
Youming Lu, Huazhong University of Science and Technology, Wuhan, China
Do Sik Min, Pusan National University, Pusan, Korea
Inhee Mook-Jung, Seoul National University, Seoul, Korea
Nozomu Mori, Nagasaki University, Nagasaki, Japan
Il-Hoan Oh, The Catholic University of Korea, Seoul, Korea
Sun Ha Paek, Seoul National University, Seoul, Korea
Youngmi Kim Pak, Kyung Hee University, Seoul, Korea
Jae-Yong Park, Gyeongsang National University, Jinju, Korea
Randy Y.C. Poon, Hong Kong University of Science and Technology, Hong Kong, Hong Kong
Hideyuki Saya, Keio University, Tokyo, Japan
Philipp E. Scherer, University of Texas Southwestern Medical Center, Dallas, U.S.A.
Jeong-Sun Seo, Seoul National University, Seoul, Korea
Iichiro Shimomura, Osaka University, Osaka, Japan
Evan Snyder, Sanford-Burnham Medical Research Institute, La Jolla, U.S.A.
Jonathan Sprent, Garvan Institute of Medical Research, Sydney, Australia
Joohon Sung, Seoul National University, Seoul, Korea
Young Chul Sung, Pohang University of Science and Technology, Pohang, Korea
Young-Joon Surh, Seoul National University, Seoul, Korea
Soo-Jong Um, Sejong University, Seoul, Korea
Jose A. Villadangos, The University of Melbourne, Melbourne, Australia
Huaxi Xu, Sanford-Burnham Medical Research Institute, La Jolla, U.S.A.
Akihiko Yoshimura, Keio University, Tokyo, Japan
Submission enquiries, recommendations for review topics and all other author enquiries should be directed to the Editorial Office at ksbmb3@ksbmb.or.kr.
Editorial Office
Experimental & Molecular Medicine
635-4 Korean Federation of Science Societies Building
Room # 812
Yeoksam 1-dong
Gangnam-gu
Seoul 135-703
Republic of Korea
Tel: +82 2 565 1621
Fax: +82 2 508 7578
E-mail: ksbmb3@ksbmb.or.kr
|
刊名字顺( Alphabetical List of Journals):
返回页首 